150 related items for PubMed ID: 10216806
1. Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Argenziano L, Trimarco B.
Curr Med Res Opin; 1999; 15(1):9-14. PubMed ID: 10216806
[Abstract] [Full Text] [Related]
2. Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Levine B.
Curr Med Res Opin; 1999; 15(1):25-32. PubMed ID: 10216808
[Abstract] [Full Text] [Related]
3. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Gavras I, Gavras H.
Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
[Abstract] [Full Text] [Related]
4. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.
Elliott WJ.
J Hum Hypertens; 1999 Jun; 13(6):413-7. PubMed ID: 10408592
[Abstract] [Full Text] [Related]
5. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Sega R.
Blood Press; 1999 Jun; 8(2):114-21. PubMed ID: 10451039
[Abstract] [Full Text] [Related]
6. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
Diamond JA, Gharavi A, Roychoudhury D, Machac J, Henzlova MJ, Travis A, Phillips RA.
Curr Med Res Opin; 1999 Jun; 15(1):1-8. PubMed ID: 10216805
[Abstract] [Full Text] [Related]
7. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Leu HB, Charng MJ, Ding PY.
Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
[Abstract] [Full Text] [Related]
8. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
Ruilope L, Jäger B, Prichard B.
Blood Press; 2001 Jul; 10(4):223-9. PubMed ID: 11800061
[Abstract] [Full Text] [Related]
9. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE.
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[Abstract] [Full Text] [Related]
10. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E, Bombelli M, Cerasola G, Cipollone F, Ferri C, Grazioli I, Leprotti C, Mancia G, Melzi G, Mugellini A, Mulè G, Palasciano G, Salvetti A, Trimarco B.
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[Abstract] [Full Text] [Related]
11. Eprosartan: a review of its use in hypertension.
Plosker GL.
Drugs; 2009 Jun; 69(17):2477-99. PubMed ID: 19911859
[Abstract] [Full Text] [Related]
12. Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
Gradman AH, Gray J, Maggiacomo F, Punzi H, White WB.
Clin Ther; 1999 Mar; 21(3):442-53. PubMed ID: 10321414
[Abstract] [Full Text] [Related]
13. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A, Verboom CN, Jäger B.
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[Abstract] [Full Text] [Related]
14. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B.
Curr Med Res Opin; 2001 Mar; 17(1):8-17. PubMed ID: 11464450
[Abstract] [Full Text] [Related]
15. Clinical profile of eprosartan.
Puig JG, López MA, Bueso TS, Bernardino JI, Jiménez RT, Grupo MAPA-MADRID Investigators.
Cardiovasc Drugs Ther; 2002 Dec; 16(6):543-9. PubMed ID: 12766389
[Abstract] [Full Text] [Related]
16. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
17. Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Breeze E, Rake EC, Donoghue MD, Fletcher AE.
J Hum Hypertens; 2001 Dec; 15(12):857-62. PubMed ID: 11773988
[Abstract] [Full Text] [Related]
18. Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Rake EC, Breeze E, Fletcher AE.
J Hum Hypertens; 2001 Dec; 15(12):863-7. PubMed ID: 11773989
[Abstract] [Full Text] [Related]
19. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T, Himmelmann A.
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[Abstract] [Full Text] [Related]
20. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Tikkanen I, Omvik P, Jensen HA.
J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
